Immunization, measles second dose in Low income
Low income: Immunization, measles second dose was 53.1% in 2024. ◆ Volatile
Immunization, measles second dose in Low income, 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
The most recent figure for immunization, measles second dose in Low income is 53.1%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 24.0% on the previous year and up 272.5% over ten years.
Over the whole period, immunization, measles second dose in Low income peaked at 53.1% in 2024 and was at its lowest, 2.9%, in 2000.
Low income ranks 38th of 43 groups on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, measles second dose in Low income, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2000 | 2.9% | — |
| 2001 | 3.0% | +2.7% |
| 2002 | 3.0% | -0.1% |
| 2003 | 2.9% | -2.5% |
| 2004 | 3.0% | +1.6% |
| 2005 | 4.4% | +48.3% |
| 2006 | 5.2% | +18.3% |
| 2007 | 4.6% | -10.9% |
| 2008 | 7.4% | +61.1% |
| 2009 | 7.7% | +3.6% |
| 2010 | 8.3% | +8.3% |
| 2011 | 8.2% | -1.7% |
| 2012 | 9.3% | +13.6% |
| 2013 | 13.1% | +40.1% |
| 2014 | 14.3% | +9.2% |
| 2015 | 19.1% | +33.6% |
| 2016 | 24.0% | +26.0% |
| 2017 | 25.2% | +5.0% |
| 2018 | 26.2% | +4.0% |
| 2019 | 32.5% | +23.9% |
| 2020 | 34.0% | +4.8% |
| 2021 | 34.3% | +0.7% |
| 2022 | 38.9% | +13.6% |
| 2023 | 42.9% | +10.1% |
| 2024 | 53.1% | +24.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.4% | 2.9% | 7.7% | 10 |
| 2010s | 18.0% | 8.2% | 32.5% | 10 |
| 2020s | 40.6% | 34.0% | 53.1% | 5 |
Countries ranked near Low income
More health data for Low income
- Population ages 40-44, female, per capita 0.0225 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.027 units per person (2025)
- Population ages 40-44, female, annual growth rate 3.49 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 3.59 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0218 units per person (2025)
- Population ages 35-39, male, annual growth rate 3.86 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 3.55 % change on previous year (2025)
Frequently asked questions
- What is immunization, measles second dose in Low income?
- Immunization, measles second dose in Low income was 53.1% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Low income?
- The highest recorded value was 53.1% in 2024.
- What is the lowest immunization, measles second dose recorded in Low income?
- The lowest recorded value was 2.9% in 2000.
- How does Low income rank for immunization, measles second dose?
- Low income ranks 38th out of 43 groups with data for 2024.
- Is immunization, measles second dose rising or falling in Low income?
- Over the last ten years it is up 272.5%. The long-run trend across the full record is volatile.
- Where does this Low income data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.